SC
Subhashini Chakaravarthy Rangamani
About Subhashini Chakaravarthy Rangamani
Data last updated:
Subhashini Chakaravarthy Rangamani has 20 years in corporate governance. Holds Director role. Currently with 1 company, including Aristogene Biosciences Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Aristogene Biosciences Private Limited at ₹5.85 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Jan 2006 | 2006 | ₹5.85 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subhashini Chakaravarthy Rangamani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subhashini Chakaravarthy Rangamani
Subhashini Chakaravarthy Rangamani has 20 years in corporate governance. Holds Director role. Currently with 1 company, including Aristogene Biosciences Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Aristogene Biosciences Private Limited at ₹5.85 Cr (FY 2025).
Subhashini Chakaravarthy Rangamani is associated with 1 company as Director, including Aristogene Biosciences Private Limited (₹5.85 Cr).
Subhashini Chakaravarthy Rangamani has expertise in General Business.
Subhashini Chakaravarthy Rangamani has 20 years in corporate governance.
By reported revenue, the largest current company of Subhashini Chakaravarthy Rangamani is Aristogene Biosciences Private Limited, with revenue of ₹5.85 Cr (FY 2025).
Subhashini Chakaravarthy Rangamani currently holds positions at 1 company: Aristogene Biosciences Private Limited (₹5.85 Cr).